Anti-nucleocapsid Antibody Response After Two Doses of CoronaVac® Among Healthcare Workers
Introduction: The Coronavirus disease-2019 (COVID-19) pandemic that started over two years ago has led to high mortality and morbidity. Vaccine studies have been initiated worldwide to end the pandemic, and the CoronaVac® vaccine was first administered to healthcare workers at high risk of COVID-19...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Turco |
| منشور في: |
Galenos Yayinevi
2022-05-01
|
| سلاسل: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://mjima.org/text.php?&id=322 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|